Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension

View source ↗

Summary

A study to evaluate the efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus and hypertension; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (Farxiga) (dapagliflozin)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Diabetes Mellitus, Hypertension | Status: RECRUITING